---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-029684"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:22:13.073547+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# LifeStance Health appoints Teresa DeLuca to board of directors

## Summary
- Board appointed Teresa DeLuca as a director effective March 12, 2024.
- No departures or other board changes announced.
- Appointment fills a board vacancy or adds new director; no material compensation terms disclosed.

## SEC filing metadata
- accession: 0000950170-24-029684
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017024029684/0000950170-24-029684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017024029684/lfst-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-029684
- JSON: https://secwatch.observer/filing/0000950170-24-029684.json
- Plain text: https://secwatch.observer/filing/0000950170-24-029684.txt

## Key facts
- Executive change
  Teresa DeLuca was appointed as director at LifeStance Health Group, Inc..
  - Action: appointed
  - Role: director
  source text: On March 12, 2024, the Company’s Board of Directors (the “Board”) appointed Teresa DeLuca as a director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000095017024029684/0000950170-24-029684-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.